Skip to main content
Skip to main content
Go to homepage

Plecanatide in Children 6 to <18 with IBS-C

Safety and Efficacy of Plecanatide in Children 6 to < 18 with Irritable Bowel Syndrome with Constipation (IBS-C)

Description:

View complete study details here.

Interested in participating?
We are currently recruiting
Study Sponsor:

Bausch Health Americas, Inc

Full IRB Study Title:
A randomized, double-blind, placebo-controlled, dose ranging, parallel-group study of the efficacy and safety of Plecanatide in Children 6 to < 18 Years of Age with Irritable Bowel Syndrome with Constipation (IBS-C) Protocol: SP304202-14
IRB Study ID:
1548588
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Sirvart Kassabian, MD

Pediatric Gastroenterologist
Pediatric Gastroenterology